Role of radiotherapy in the treatment of metastatic head and neck cancer
暂无分享,去创建一个
[1] U. Ricardi,et al. Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach , 2016, Journal of radiation research.
[2] A. Bujold,et al. Palliative Radiation Therapy for Advanced Head and Neck Carcinomas: A Phase 2 Study. , 2016, International journal of radiation oncology, biology, physics.
[3] Peihong Wu,et al. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma. , 2016, Radiology.
[4] R. Tishler,et al. Radiation Oncology--New Approaches in Squamous Cell Cancer of the Head and Neck. , 2015, Hematology/oncology clinics of North America.
[5] R. Sun,et al. Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survival , 2015, Oncotarget.
[6] E. Cohen,et al. Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] H. Mehanna,et al. Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta‐analysis , 2015, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[8] Ying Huang,et al. Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors , 2014, PloS one.
[9] J. Thariat,et al. Local ablative treatments of oligometastases from head and neck carcinomas. , 2014, Critical reviews in oncology/hematology.
[10] P. Busse,et al. Long-term survival after distant metastasis in patients with oropharyngeal cancer. , 2014, Oral oncology.
[11] John Wong,et al. Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. , 2013, International journal of radiation oncology, biology, physics.
[12] Oleksiy Karpenko,et al. Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs , 2012, PloS one.
[13] C. Belka,et al. Dying cell clearance and its impact on the outcome of tumor radiotherapy , 2012, Front. Oncol..
[14] R. Onimaru,et al. Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence , 2012, Pulmonary medicine.
[15] L. Dawson,et al. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma. , 2011, International journal of radiation oncology, biology, physics.
[16] E. Kunieda,et al. Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] Liru He,et al. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment? , 2011, Oral oncology.
[18] N. Ikeda,et al. Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas. , 2009, The Annals of thoracic surgery.
[19] N. Kawashima,et al. Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody , 2009, Clinical Cancer Research.
[20] L. Gaspar,et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] P. Okunieff,et al. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses. , 2009, International journal of radiation oncology, biology, physics.
[22] Masahiro Hiraoka,et al. Stereotactic body radiotherapy for oligometastatic lung tumors. , 2008, International journal of radiation oncology, biology, physics.
[23] Robert D Timmerman,et al. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. , 2008, Seminars in radiation oncology.
[24] P. Pai,et al. Hypofractionated, palliative radiotherapy for advanced head and neck cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] C. Bokemeyer,et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.
[26] B. Hickey,et al. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial". , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] M. Schell,et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. , 2007, International journal of radiation oncology, biology, physics.
[28] R. Weichselbaum,et al. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells , 2007, The Journal of experimental medicine.
[29] H. Willers,et al. Introduction to clinical radiation biology. , 2006, Hematology/oncology clinics of North America.
[30] L. Peters,et al. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] Samuel Ryu,et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. , 2004, International journal of radiation oncology, biology, physics.
[32] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[33] B. Mohanti,et al. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] K. Camphausen,et al. Radiation abscopal antitumor effect is mediated through p53. , 2003, Cancer research.
[35] C. Silver,et al. Incidence and Sites of Distant Metastases from Head and Neck Cancer , 2001, ORL.
[36] V. Rusch,et al. Pulmonary Metastasectomy for Head and Neck Cancers , 1999, Annals of Surgical Oncology.
[37] M. Nakamizo,et al. Surgical treatment for pulmonary metastases of squamous cell carcinoma of the head and neck. , 1997, American journal of otolaryngology.
[38] N. Petrelli,et al. Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck. , 1992, American journal of surgery.
[39] R. Weichselbaum,et al. The immunology of ablative radiation. , 2015, Seminars in radiation oncology.
[40] D. Kallogjeri,et al. Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes. , 2014, Oral oncology.
[41] Wei Xu,et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. , 2013, Oral oncology.
[42] R. Weichselbaum,et al. Oligometastases revisited , 2011, Nature Reviews Clinical Oncology.